Nevertheless, the combined detection of CEA, a commercial CRC biomarker, together with FN1 and CEA in crude plasma/serum samples showed an improvement of CRC diagnostic performance when compared to that detected by CEA level alone (Figure 7). The gene discussed is FN1; the disease is colorectal carcinoma.